JP Patent

JP7105065B2 — リガンド修飾二本鎖核酸

Assigned to Dicerna Pharmaceuticals Inc · Expires 2022-07-22 · 4y expired

What this patent protects

Patent listed against nedosiran-sodium.

Drugs covered by this patent

nedosiran-sodium (NEDOSIRAN SODIUM)

Patent Metadata

Patent number: JP7105065B2
Jurisdiction: JP
Classification: —
Expires: 2022-07-22
Drug substance claim: No
Drug product claim: No
Assignee: Dicerna Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.